BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1205019)

  • 1. Small and large vessel disease in the development of foot lesions in diabetics.
    Fair I
    Diabetologia; 1975 Aug; 11(4):249-53. PubMed ID: 1205019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood flow in diabetics with foot lesions due to 'small vessel disease'.
    Irwin ST; Gilmore J; McGrann S; Hood J; Allen JA
    Br J Surg; 1988 Dec; 75(12):1201-6. PubMed ID: 3233470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does diabetic microangiopathy cause development of gangrene?
    Nielsen PE
    Scand J Clin Lab Invest Suppl; 1973; 128():229-34. PubMed ID: 4764588
    [No Abstract]   [Full Text] [Related]  

  • 4. Foot lesions in diabetic patients: pathogenesis and management.
    Faris I
    Med J Aust; 1977 Apr; 1(17):628-33. PubMed ID: 875813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular disease and vascular function in the lower limb in diabetes.
    Faris I; Duncan H
    Diabetes Res; 1984 Nov; 1(4):171-7. PubMed ID: 6529889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: The significance of small vessel disease in the pathogenesis of neuropathic foot lesions in diabetic patients.
    Faris IB; Le Quesne LP
    Br J Surg; 1974 Apr; 61(4):320-1. PubMed ID: 4832646
    [No Abstract]   [Full Text] [Related]  

  • 7. Skin perfusion pressure in the prediction of healing in diabetic patients with ulcers or gangrene of the foot.
    Faris I; Duncan H
    J Vasc Surg; 1985 Jul; 2(4):536-40. PubMed ID: 4009834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive characterisation of angiopathy in the diabetic foot.
    Lepäntalo M; Kangas T; Pietilä J; Scheinin T; Scheinin TM
    Eur J Vasc Surg; 1988 Feb; 2(1):41-5. PubMed ID: 3224717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of foot ulcers in diabetic patients].
    Strbová L; Krahulec B; Waczulíková I; Gaspar L; Ambrózy E
    Vnitr Lek; 2009 Oct; 55(10):918-24. PubMed ID: 19947234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of toe blood pressure is an effective screening method to identify diabetes patients with lower extremity arterial disease.
    Sahli D; Eliasson B; Svensson M; Blohmé G; Eliasson M; Samuelsson P; Ojbrandt K; Eriksson JW
    Angiology; 2004; 55(6):641-51. PubMed ID: 15547650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Caribbean experience with the diabetic foot management of the diabetic foot.
    Walrond ER
    West Indian Med J; 2001 Mar 1-4; 50 Suppl 1():24-6. PubMed ID: 15973811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for the development of foot lesions in Nigerian patients with diabetes mellitus.
    Akanji AO; Bella AF; Agbedana EO; Osotimehin BO; Adetuyibi A
    East Afr Med J; 1988 Sep; 65(9):602-8. PubMed ID: 3224569
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetic osteoarthropathy].
    Ulreich A; Stradner F; Schreyer H; Rainer F
    Wien Med Wochenschr; 1984 Jun; 134(11):265-9. PubMed ID: 6464472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of the diabetic foot (with special reference to diabetic gangrene)].
    Orv Hetil; 1993 May; 134(21):1167-8. PubMed ID: 8502469
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetic infection, ulceration and gangrene.
    Rice JS
    J Am Podiatry Assoc; 1974 Oct; 64(10):774-81. PubMed ID: 4412792
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between diabetic-autonomic-C-fibre-neuropathy and medial wall calcification and the significance in the outcome of trophic foot lesions.
    Forst T; Pfützner A; Kann P; Lobmann R; Schäfer H; Beyer J
    Exp Clin Endocrinol Diabetes; 1995; 103(2):94-8. PubMed ID: 7553081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The diabetic foot].
    Casparie AF
    Ned Tijdschr Geneeskd; 1978 Feb; 122(5):137-41. PubMed ID: 625355
    [No Abstract]   [Full Text] [Related]  

  • 18. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?
    McNeely MJ; Boyko EJ; Ahroni JH; Stensel VL; Reiber GE; Smith DG; Pecoraro RF
    Diabetes Care; 1995 Feb; 18(2):216-9. PubMed ID: 7729300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [LIMITED DISTAL GANGRENE OF THE FOOT AND THE RESULTS OBTAINED WITH OUR THERAPEUTIC ORIENTATION. (CONSIDERATIONS ON TRANSMETATARSAL AMPUTATIONS)].
    DEGNI M; CHAINMAIA A
    Angiologia; 1964; 16():29-36. PubMed ID: 14111496
    [No Abstract]   [Full Text] [Related]  

  • 20. Noninvasive assessment of toe systolic pressures with special reference to diabetes mellitus.
    Vincent DG; Salles-Cunha SX; Bernhard VM; Towne JB
    J Cardiovasc Surg (Torino); 1983; 24(1):22-8. PubMed ID: 6833348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.